Navigation Links
Therapeutic melanoma vaccine improves response rate, progression-free survival
Date:6/2/2011

HOUSTON ― A vaccine for one of the most lethal cancers, advanced melanoma, has improved response rate and progression-free survival for patients when combined with the immunotherapy drug Interleukin-2, according to research led by scientists from The University of Texas MD Anderson Cancer Center and Indiana University Health Goshen Center for Cancer Care.

The findings, published in the June 2 New England Journal of Medicine, mark the first vaccine study in the disease and one of the first in cancer overall to show clinical benefit in a randomized Phase III clinical trial. It's also the first cancer vaccine to show an improved response rate in patients.

The research was first presented on the plenary session of 2009 American Society of Clinical Oncology.

According to the American Cancer Society, melanoma has one of the fastest growing incidence rates of all cancers. In 2010, more than 68,130 people in the U.S. were diagnosed with melanoma and 8,700 died from the disease. The five-year survival rates for those with regional and metastatic disease are 65 percent and 16 percent, respectively.

"Obviously, this is a disease, in its advanced setting, in need of better therapies for patients," said Patrick Hwu, M.D., professor and Chair of the Department of Melanoma Medical Oncology and the study's senior author. "This study serves as a proof-of-principle for the role of vaccines in melanoma and in cancer therapy overall. If we can use the body's own defense system to attack tumor cells, we provide a mechanism for ridding the body of cancer without destroying healthy tissue."

During their tenure at the National Cancer Institute NCI), Hwu and Douglas Schwartzentruber, M.D., the medical director of the Goshen Center for Cancer Care, were involved in the vaccine's development and early basic and clinical studies. The peptide vaccine, known as gp100:209-217 (200M), works by stimulating patients' T cells, kno
'/>"/>

Contact: Laura Sussman
lsussman@mdanderson.org
832-264-8893
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Heart drug cuts prostate cancer risk; holds potential for therapeutic use
2. New therapeutic target for lung cancer
3. McCain gives $5 million to St. Michael’s Hospital for therapeutic endoscopy
4. Researchers discover possible biomarker and therapeutic target for melanoma
5. Study identifies therapeutic target for liver cancer and predictive biomarker of response
6. Therapeutic lifestyle changes as useful as drugs in improving mental health
7. Mayo Clinic researchers confirm value of therapeutic hypothermia after cardiac arrest
8. Study compares balanced propofol sedation with conventional sedation for therapeutic GI endoscopic procedures
9. Save messengers -- modified mRNAs open up new therapeutic possibilities
10. Transplanted human placenta-derived stem cells show therapeutic potential in stroke models
11. Optimizing patient outcomes after therapeutic hypothermia for traumatic brain injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Alan Mozes HealthDay Reporter ... it comes to emergency room waiting times, patients seeking care ... staring down the clock than those seen at smaller or ... crowding and our ability to provide timely emergency care varies ... the authors of the new research, Dr. Renee Hsia, an ...
(Date:9/18/2014)... together with the Chinese Thoracic Society (CTS) announced ... CHEST World Congress 2016 will be held in ... sleep medicine from around the world are expected ... 2016. , CHEST World Congress 2016 will ... keynote addresses, presentations by leading health-care experts, and ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Qualis Health, ... has published a white paper, “Advancing Primary Care ... Health Information Technology.” , Authors Jeff Hummel, MD, ... provide guidance to organizations engaged in the work of ... health IT can bolster PCMH objectives, such as generating ...
(Date:9/18/2014)... scientists have developed a new method to study Ebola ... The Wildlife Conservation Society (WCS)-led research, published today in ... the use of fecal samples from wild great apes ... the virus. This represents a new tool for performing ... way Ebola virus is studied and improve our understanding ...
(Date:9/18/2014)... guidelines recommending that elderly men should not be routinely ... according to a new study led by researchers at ... letter online in JAMA Internal Medicine , focused ... to test for prostate cancer., "We found that the ... of elderly men in particular has been minimal at ...
Breaking Medicine News(10 mins):Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3Health News:CHEST announces China as site of CHEST World Congress 2016 2Health News:Advancing Primary Care Through PCMH and HIT: New White Paper Connects the Dots 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 3Health News:Professional recommendations against routine prostate cancer screening have little effect 2
... most comprehensive analyses to date of the cost of robotic-assisted, ... this now-dominant surgical approach is significantly more costly than standard ... outcomes. The results of the study are available online and ... Urology . In one of the first studies ...
... we age help keep us sharp in later life, new ... Older people with robust brain ,wiring, that is, the ... process information quickly and that this makes them generally smarter, ... distant parts of the brain together with better wiring improves ...
... WEDNESDAY, May 23 (HealthDay News) -- The use of ... a multi-pronged approach that includes more training and supportive ... new German study. Despite legal regulations and evidence ... rails and belts still are frequently used in nursing ...
... researchers will present findings on prostate cancer risk, screening, ... of the American Urological Association May 19-23 in Atlanta. ... expert comment for reporters covering the conference. Mayo ... dates include: No negative impact on overall ...
... Reporter , TUESDAY, May 22 (HealthDay News) -- New research ... snoring and daytime sleepiness, might also cut down on a ... of developing high blood pressure. Researchers in Spain examined ... two groups with sleep apnea who used continuous positive airway ...
... , TUESDAY, May 22 (HealthDay News) -- Researchers who ... of precancerous colon lesions recommend people with the blood ... than others. "Based on our data, it implies ... at age 40, rather than at age 50," said ...
Cached Medicine News:Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 3Health News:Well-connected brains make you smarter in older age 2Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 2Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 3
(Date:9/18/2014)... 18, 2014 MiMedx Group, Inc. (NASDAQ: ... and marketer of patent protected regenerative biomaterials and ... that it has entered into a distribution agreement ... provide its dehydrated human amnion/chorion membrane ("dHACM") allograft ... on a private label basis. The ...
(Date:9/18/2014)... and PLAINSBORO, N.J. ... today its support of the National Hemophilia Foundation,s ... , which provides support to people with hemophilia ... and psychosocial challenges that can impede disease management. ... modules, Communication With Your Provider About Pain ...
(Date:9/18/2014)... 18, 2014 After 6 months of ... finally here - the new programme for the next Cool ... of our global Cool Chain series, has just been released! ... As the lines between supply chain, logistics, QA ... programme that is broad and yet specific, focused and yet ...
Breaking Medicine Technology:MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 2Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 3Europe's Biggest and Longest-Running Gathering of Life Sciences Logistics, Supply Chain & QA Professionals 2
... Calif., Nov. 16, 2011 ZONARE Medical Systems ... Frost & Sullivan 2011 North American Technology Innovation ... in the development of Zone Sonography Technology (ZST), ... as one of the industry,s most significant ultrasound ...
... Unigene Laboratories, Inc. (OTCBB: UGNE), ... peptide-based therapeutics, today announced the appointment of Thomas J. Sabatino, ... is currently Executive Vice President and General Counsel for Walgreen ... ), based in Deerfield, IL.  He joined Walgreens in September ...
Cached Medicine Technology:Frost & Sullivan Honors ZONARE for Ultrasound Innovation 2Unigene Strengthens Board with the Appointment of Walgreen's Executive, Thomas J. Sabatino, Jr. 2Unigene Strengthens Board with the Appointment of Walgreen's Executive, Thomas J. Sabatino, Jr. 3Unigene Strengthens Board with the Appointment of Walgreen's Executive, Thomas J. Sabatino, Jr. 4
Patent Pending lateral flow assay platform that contributes to increased sensitivty...
Colloidal Gold Conjugated, Streptavidin - 50 OD...
Colloidal Gold Conjugated, Goat anti-mouse IgG (H&L) - 12 OD...
Colloidal Gold Conjugated, Goat anti-human IgM (Mu Chain) - 12 OD...
Medicine Products: